Edwards Lifesciences Corp (EW)vsInspire Medical Systems Inc (INSP)
EW
Edwards Lifesciences Corp
$85.96
-1.70%
HEALTHCARE · Cap: $49.01B
INSP
Inspire Medical Systems Inc
$41.19
-2.37%
HEALTHCARE · Cap: $1.23B
Smart Verdict
WallStSmart Research — data-driven comparison
Edwards Lifesciences Corp generates 589% more annual revenue ($6.30B vs $915.25M). EW leads profitability with a 17.4% profit margin vs 14.3%. INSP trades at a lower P/E of 9.7x. EW earns a higher WallStSmart Score of 61/100 (C+).
EW
Buy61
out of 100
Grade: C+
INSP
Buy56
out of 100
Grade: C
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
+68.7%
Fair Value
$253.29
Current Price
$85.96
$167.33 discount
Margin of Safety
+85.3%
Fair Value
$462.74
Current Price
$41.19
$421.55 discount
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Strong operational efficiency at 31.2%
Conservative balance sheet, low leverage
Safe zone — low bankruptcy risk
16.7% revenue growth
Attractively priced relative to earnings
Reasonable price relative to book value
Earnings expanding 308.4% YoY
Conservative balance sheet, low leverage
Safe zone — low bankruptcy risk
Areas to Watch
Expensive relative to growth rate
Weak financial health signals
Premium valuation, high expectations priced in
Negative free cash flow — burning cash
1.6% revenue growth
Smaller company, higher risk/reward
Operating margin of -0.6%
Comparative Analysis Report
WallStSmart ResearchBull Case : EW
The strongest argument for EW centers on Operating Margin, Debt/Equity, Altman Z-Score. Profitability is solid with margins at 17.4% and operating margin at 31.2%. Revenue growth of 16.7% demonstrates continued momentum.
Bull Case : INSP
The strongest argument for INSP centers on P/E Ratio, Price/Book, EPS Growth.
Bear Case : EW
The primary concerns for EW are PEG Ratio, Piotroski F-Score, P/E Ratio. A P/E of 46.0x leaves little room for execution misses.
Bear Case : INSP
The primary concerns for INSP are Revenue Growth, Market Cap, Operating Margin.
Key Dynamics to Monitor
EW profiles as a growth stock while INSP is a value play — different risk/reward profiles.
EW carries more volatility with a beta of 0.87 — expect wider price swings.
EW is growing revenue faster at 16.7% — sustainability is the question.
INSP generates stronger free cash flow (3M), providing more financial flexibility.
Bottom Line
EW scores higher overall (61/100 vs 56/100), backed by strong 17.4% margins and 16.7% revenue growth. INSP offers better value entry with a 85.3% margin of safety. Both earn "Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Edwards Lifesciences Corp
HEALTHCARE · MEDICAL DEVICES · USA
Edwards Lifesciences is an American medical technology company headquartered in Irvine, California, specializing in artificial heart valves and hemodynamic monitoring.
Visit Website →Inspire Medical Systems Inc
HEALTHCARE · MEDICAL DEVICES · USA
Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and Europe. The company is headquartered in Golden Valley, Minnesota.
Compare with Other MEDICAL DEVICES Stocks
Want to dig deeper into these stocks?